AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34561142 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepa-B vaccine
Number of subjects: 158
Study 34561142 — intervention group
Group type: COMPARATOR
Intervention: Engerix-B vaccine
Number of subjects: 158
Study 34561142 — intervention group
Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 158
Study 34968694 — intervention group
Group type: EXPERIMENTAL
Intervention: Press-fit short humeral stems
Number of subjects: 41
Study 34968694 — intervention group
Group type: COMPARATOR
Intervention: Cemented standard-length humeral stems
Number of subjects: 41
Study 34968694 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 41
Study 34506317 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in the BEST-CLI trial (number of sites in the region)
Number of subjects: 9231909
Study 34506317 — intervention group
Group type: COMPARATOR
Intervention: Regional amputation rates per 1000 CLI patients
Number of subjects: 9231909
Study 32291261 — intervention group
Group type: EXPERIMENTAL
Intervention: Manuscripts published in ICMJE member journals
Number of subjects: 10500
Study 32291261 — intervention group
Group type: EXPERIMENTAL
Intervention: Published trials in ICMJE member journals
Number of subjects: 10500
Study 32291261 — intervention group
Group type: EXPERIMENTAL
Intervention: Trials registered retrospectively within a year of submission
Number of subjects: 10500
Study 32291261 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrospective registrations within the first three to eight weeks after enrolment
Number of subjects: 10500
Study 32291261 — intervention group
Group type: EXPERIMENTAL
Intervention: 286 RCTs registered retrospectively in ICMJE member journals
Number of subjects: 10500
Study 36348280 — intervention group
Group type: EXPERIMENTAL
Intervention: CRANIUM intervention (preventive care screening intervention)
Number of subjects: 536
Study 36348280 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 536
Study 34020737 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral motor intervention (OMI)
Number of subjects: 112
Study 32690067 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive cognitive rehabilitation program (comprehensive training including psycho-education, fatigue management, and cognitive strategy training with individual guidance)
Number of subjects: 261
Study 32690067 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic cognitive rehabilitation program (brief cognitive training including psycho-education and fatigue management without individual guidance)
Number of subjects: 261
Study 32690067 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 261
Study 32690067 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention groups (basic and extensive)
Number of subjects: 261
Study 36041848 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month text message-based CME intervention
Number of subjects: 0
Study 36041848 — intervention group
Group type: EXPERIMENTAL
Intervention: Future 9-month national program
Number of subjects: 0
Study 36041848 — intervention group
Group type: EXPERIMENTAL
Intervention: Full 10-year scaled-up program
Number of subjects: 0
Study 33427884 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment performed by Associate Clinicians (ACs)
Number of subjects: 230
Study 33427884 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment performed by Medical Doctors (MDs)
Number of subjects: 230
Study 33591142 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway LMA‐Supreme™ (LMAS) placement with neuromuscular blocking agents (NMBAs)
Number of subjects: 432
Study 33591142 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway LMA‐Supreme™ (LMAS) placement without neuromuscular blocking agents (NMBAs)
Number of subjects: 432
Study 33591142 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway LMA‐Supreme™ (LMAS) placement with Mallampati III‐IV
Number of subjects: 432
Study 33591142 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway LMA‐Supreme™ (LMAS) placement with inter‐incisor distance < 3 cm
Number of subjects: 432
Study 33591142 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway LMA‐Supreme™ (LMAS) placement with reduced neck mobility
Number of subjects: 432
Study 34564706 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee consumption (more than 14 cups per week) in rapid metabolizers
Number of subjects: 18
Study 34564706 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee consumption
Number of subjects: 18
Study 34564706 — intervention group
Group type: EXPERIMENTAL
Intervention: High coffee consumption
Number of subjects: 18
Study 34564706 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP1A2 rs762551 polymorphism
Number of subjects: 18
Study 32907390 — intervention group
Group type: EXPERIMENTAL
Intervention: IOP at 6 AM in POAG group
Number of subjects: 65
Study 32907390 — intervention group
Group type: EXPERIMENTAL
Intervention: ∆IOP in POAG group
Number of subjects: 65
Study 32907390 — intervention group
Group type: EXPERIMENTAL
Intervention: IOP at 6 AM in GS group
Number of subjects: 65
Study 36095067 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 33629251 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy regimens (platinum-based therapy)
Number of subjects: 0
Study 33629251 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy
Number of subjects: 0
Study 33629251 — intervention group
Group type: EXPERIMENTAL
Intervention: Ongoing and future studies
Number of subjects: 0
Study 32304159 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week Accredited Exercise Physiologist-led exercise program
Number of subjects: 59
Study 32304159 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59
Study 32304159 — intervention group
Group type: EXPERIMENTAL
Intervention: Partners-in-care perspective
Number of subjects: 59
Study 35533496 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 0
Study 35533496 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycobacterial antigen-specific polyfunctional effector memory Th1 responses at 6-10 weeks
Number of subjects: 0
Study 33118896 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational programme exploring biodiversity of tomato
Number of subjects: 136
Study 33118896 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual class activities)
Number of subjects: 136
Study 36337878 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon catheter ablation (CA)
Number of subjects: 204
Study 36337878 — intervention group
Group type: COMPARATOR
Intervention: Anti-arrhythmic drug (AAD)
Number of subjects: 204
Study 34663787 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem Solving Therapy
Number of subjects: 249
Study 34663787 — intervention group
Group type: COMPARATOR
Intervention: Engage therapy
Number of subjects: 249
Study 32901826 — intervention group
Group type: EXPERIMENTAL
Intervention: 110 µm cap thickness
Number of subjects: 100
Study 32901826 — intervention group
Group type: COMPARATOR
Intervention: 140 µm cap thickness
Number of subjects: 100
Study 34524097 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewers of 13RW‐3 (intervention group)
Number of subjects: 157
Study 34524097 — intervention group
Group type: COMPARATOR
Intervention: Nonviewers of 13RW‐3 (control group)
Number of subjects: 157
Study 32334980 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-powered convex lenses (+0.50D, +0.75D, +1.25D)
Number of subjects: 0
Study 32334980 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-powered convex lenses (+0.50D and +0.75D)
Number of subjects: 0
Study 32334980 — intervention group
Group type: COMPARATOR
Intervention: Plano lenses (control)
Number of subjects: 0
Study 35666376 — intervention group
Group type: EXPERIMENTAL
Intervention: App‐based food‐specific inhibitory control training
Number of subjects: 94
Study 35666376 — intervention group
Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 94
Study 34528994 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone educational intervention on breastfeeding self-efficacy
Number of subjects: 240
Study 34528994 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 240
Study 36335517 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg/d)
Number of subjects: 169
Study 36335517 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study 36335517 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 169
Study 34187532 — intervention group
Group type: EXPERIMENTAL
Intervention: Corpuls CPR
Number of subjects: 19
Study 34187532 — intervention group
Group type: EXPERIMENTAL
Intervention: Physio-Control LUCAS 3
Number of subjects: 19
Study 34187532 — intervention group
Group type: EXPERIMENTAL
Intervention: Schiller Easy Pulse
Number of subjects: 19
Study 34187532 — intervention group
Group type: COMPARATOR
Intervention: LUCAS 3
Number of subjects: 19
Study 32350686 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine, Hydroxychloroquine, Lopinavir/Ritonavir, Remdesivir
Number of subjects: 0
Study 32350686 — intervention group
Group type: EXPERIMENTAL
Intervention: Other potential drugs
Number of subjects: 0
Study 35103022 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Cognitive-Behavioral Therapy with Interoceptive Exposure (GCBT-IE)
Number of subjects: 114
Study 35103022 — intervention group
Group type: COMPARATOR
Intervention: Waiting List (WL)
Number of subjects: 114
Study 34689673 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic norm messages
Number of subjects: 0
Study 34689673 — intervention group
Group type: EXPERIMENTAL
Intervention: Static norm messages
Number of subjects: 0
Study 34689673 — intervention group
Group type: COMPARATOR
Intervention: No messages (control)
Number of subjects: 0
Study 34107512 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (0.1 g·kg‐1·d‐1) during resistance training (3 d·wk‐1 for 1 yr)
Number of subjects: 70
Study 34107512 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 70
Study 34107512 — intervention group
Group type: COMPARATOR
Intervention: Placebo during resistance training
Number of subjects: 70
Study 34107512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 32302717 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended hours dialysis (≥ 24 hours/week)
Number of subjects: 200
Study 32302717 — intervention group
Group type: COMPARATOR
Intervention: Standard hours dialysis (12‐18 hours/week)
Number of subjects: 200
Study 32302717 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in ultrafiltration rate
Number of subjects: 200
Study 32302717 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in systolic blood pressure
Number of subjects: 200
Study 32302717 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in interdialytic weight gain
Number of subjects: 200
Study 32302717 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in urea clearance, phosphate, or total hours per week
Number of subjects: 200
Study 35220948 — intervention group
Group type: EXPERIMENTAL
Intervention: Single suction device for processing cumulative blood including amniotic fluid (Group 1)
Number of subjects: 34
Study 35220948 — intervention group
Group type: COMPARATOR
Intervention: Two suction devices to separate amniotic fluid from cumulative blood (Group 2)
Number of subjects: 34
Study 33885394 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical skills simulation (CSS) using standardized patient
Number of subjects: 50
Study 33885394 — intervention group
Group type: COMPARATOR
Intervention: Traditional methods of teaching behavior management
Number of subjects: 50
Study 34369941 — intervention group
Group type: COMPARATOR
Intervention: IANB (3.6 mL)
Number of subjects: 60
Study 34369941 — intervention group
Group type: COMPARATOR
Intervention: IANB plus lingual infiltration (1.8 mL IANB + 1.8 mL lingual infiltration)
Number of subjects: 60
Study 34369941 — intervention group
Group type: EXPERIMENTAL
Intervention: IANB, IANB plus buccal infiltration, IANB plus lingual infiltration
Number of subjects: 60
Study 33126910 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg once daily for 10 days)
Number of subjects: 800
Study 33126910 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (75 mg once daily for 10 days)
Number of subjects: 800
Study 33126910 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin + Atorvastatin with conventional therapy
Number of subjects: 800
Study 33126910 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care for management of COVID-19)
Number of subjects: 800
Study 35356608 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation combined with radioactive seed implantation
Number of subjects: 30
Study 35356608 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation only
Number of subjects: 30
Study 32918160 — intervention group
Group type: EXPERIMENTAL
Intervention: SLH formulations (SLH-A and SLH-B)
Number of subjects: 12
Study 32918160 — intervention group
Group type: COMPARATOR
Intervention: Commercial formulation
Number of subjects: 12
Study 32918160 — intervention group
Group type: EXPERIMENTAL
Intervention: SLH formulations
Number of subjects: 12
Study 34382353 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 19
Study 32739331 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional information present
Number of subjects: 0
Study 32739331 — intervention group
Group type: COMPARATOR
Intervention: Nutritional information absent
Number of subjects: 0
Study 35883085 — intervention group
Group type: EXPERIMENTAL
Intervention: External focus group
Number of subjects: 42
Study 35883085 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal focus group
Number of subjects: 42
Study 35883085 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study 32931645 — intervention group
Group type: EXPERIMENTAL
Intervention: ExeRTiOn online resource
Number of subjects: 17
Study 32741642 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 75 mg preoperatively
Number of subjects: 128
Study 32741642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 35444232 — intervention group
Group type: EXPERIMENTAL
Intervention: BenMel (200 mg/m2 bendamustine + 100 mg/m2 melphalan)
Number of subjects: 120
Study 35444232 — intervention group
Group type: COMPARATOR
Intervention: Mel (200 mg/m2 melphalan)
Number of subjects: 120
Study 35444232 — intervention group
Group type: EXPERIMENTAL
Intervention: BenMel
Number of subjects: 120
Study 35444232 — intervention group
Group type: COMPARATOR
Intervention: Mel
Number of subjects: 120
Study 32743758 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS with standard bifrontal montage (anode over left DLPFC, cathode over right DLPFC)
Number of subjects: 20
Study 32743758 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study 32743758 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 20
Study 33574503 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhizobium strains NSFBR‐15 and NSFBR‐12
Number of subjects: 0
Study 33574503 — intervention group
Group type: COMPARATOR
Intervention: Non-inoculated plants without N fertilizer (‐N control)
Number of subjects: 0
Study 33574503 — intervention group
Group type: COMPARATOR
Intervention: Non-inoculated plants with N fertilizer (+N control)
Number of subjects: 0
Study 32605697 — intervention group
Group type: EXPERIMENTAL
Intervention: Injected allergen-specific immunotherapy (AIT) for grass pollen allergy
Number of subjects: 38
Study 32605697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 35511051 — intervention group
Group type: EXPERIMENTAL
Intervention: Nissen fundoplication
Number of subjects: 70
Study 35511051 — intervention group
Group type: EXPERIMENTAL
Intervention: Toupet fundoplication
Number of subjects: 70
Study 32700389 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician incentives of $50 per patient per drug class
Number of subjects: 8935
Study 32700389 — intervention group
Group type: COMPARATOR
Intervention: Control group (no physician incentives)
Number of subjects: 8935
Study 33533134 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 28
Study 33533134 — intervention group
Group type: COMPARATOR
Intervention: Intense pulsed light (IPL)
Number of subjects: 28
Study 32222849 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer‐led healthy lifestyle intervention
Number of subjects: 314
Study 34342706 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery
Number of subjects: 0
Study 34342706 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic surgical resection
Number of subjects: 0
Study 34342706 — intervention group
Group type: COMPARATOR
Intervention: Open surgical approach
Number of subjects: 0
Study 36317831 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-show video discussion about the character's motives and actions
Number of subjects: 334
Study 36317831 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-show warning about an untrustworthy character
Number of subjects: 334
Study 36317831 — intervention group
Group type: COMPARATOR
Intervention: Control clip (no narrative correction)
Number of subjects: 334
Study 34008397 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime levothyroxine administration (group A)
Number of subjects: 84
Study 34008397 — intervention group
Group type: COMPARATOR
Intervention: Early morning levothyroxine administration (group B)
Number of subjects: 84
Study 32641379 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 6522
Study 32641379 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6522
Study 35272337 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video
Number of subjects: 38
Study 35272337 — intervention group
Group type: COMPARATOR
Intervention: Standard handout
Number of subjects: 38
Study 32006473 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-thymocyte globulin plus GVHD prophylaxis
Number of subjects: 99
Study 32006473 — intervention group
Group type: COMPARATOR
Intervention: Standard GVHD prophylaxis
Number of subjects: 99
Study 36347740 — intervention group
Group type: EXPERIMENTAL
Intervention: mAFA intervention
Number of subjects: 714
Study 32790913 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin + Clavulanic acid
Number of subjects: 159
Study 32790913 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin + Clavulanic acid + Probiotics
Number of subjects: 159
Study 32790913 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics or probiotics (Control)
Number of subjects: 159
Study 32482626 — intervention group
Group type: EXPERIMENTAL
Intervention: Outcome Prioritisation Tool (OPT)
Number of subjects: 114
Study 32482626 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (Control)
Number of subjects: 114
Study 36243020 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic convection-enhanced delivery of topotecan (146 μM, 200 μL/h for 48 h, followed by a 5-7 day washout period, with four total infusions)
Number of subjects: 5
Study 33686901 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 128
Study 33686901 — intervention group
Group type: EXPERIMENTAL
Intervention: Family income level
Number of subjects: 128
Study 33686901 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender
Number of subjects: 128
Study 35131486 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced intensity conditioning with bortezomib (Bz) prior to alloSCT
Number of subjects: 24
Study 35131486 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-transplant maintenance with bortezomib (Bz) and lenalidomide (Len)
Number of subjects: 24
Study 35131486 — intervention group
Group type: EXPERIMENTAL
Intervention: Event free survival (EFS) and overall survival (OS)
Number of subjects: 24
Study 34507338 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom Navi Program (SNP)
Number of subjects: 134
Study 34507338 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 134
Study 35234931 — intervention group
Group type: EXPERIMENTAL
Intervention: IPS integrated with TAU
Number of subjects: 58
Study 35234931 — intervention group
Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 58
Study 32885780 — intervention group
Group type: EXPERIMENTAL
Intervention: Invitation letter including a FIT (n = 5850)
Number of subjects: 17532
Study 32885780 — intervention group
Group type: EXPERIMENTAL
Intervention: Invitation letter including an option to request a FIT (n = 5844)
Number of subjects: 17532
Study 32885780 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder letters sent to group A
Number of subjects: 17532
Study 32885780 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder letters sent to group B
Number of subjects: 17532
Study 32885780 — intervention group
Group type: COMPARATOR
Intervention: Control group (invitation letter only, n = 5838)
Number of subjects: 17532
Study 32885780 — intervention group
Group type: EXPERIMENTAL
Intervention: FIT positivity rate
Number of subjects: 17532
Study 32885780 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsequent colonoscopy for FIT‐positive participants
Number of subjects: 17532
Study 34311059 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Training (VRT)
Number of subjects: 36
Study 34311059 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Balance Training (CBT)
Number of subjects: 36
Study 34311059 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study 34927405 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 19
Study 34927405 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated growth factors (CGF)
Number of subjects: 19
Study 34927405 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous fibrin glue (AFG)
Number of subjects: 19
Study 34927405 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study 32969717 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiomics data analysis approach
Number of subjects: 0
Study 32969717 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylation probes
Number of subjects: 0
Study 32969717 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel loci (C5orf38, SF3A3, DHX36, MRPL33)
Number of subjects: 0